文献速递类风湿关节炎

滑膜成纤维细胞作为类风湿关节炎潜在药物靶点:现状与未来方向

Synovial fibroblasts as potential drug targets in rheumatoid arthritis, where do we stand and where shall we go?
PubMed 文献 · Ann Rheum Dis · 2022-07-12

本文综述了滑膜成纤维细胞(FLS)在类风湿关节炎(RA)中的靶点潜力。FLS在炎症条件下增殖并发生表型改变,通过直接和间接破坏功能维持炎症,且作为间充质来源细胞,其抑制可能不伴随免疫抑制后果。文章总结了当前对FLS靶向治疗潜力的认识。

要点

  • FLS在RA炎症中增殖、表型改变并维持炎症。
  • FLS作为间充质来源细胞,抑制其功能可能不伴免疫抑制后果。
  • FLS是自身免疫性关节病的吸引人的细胞靶点。

核心结论

  • FLS在RA中增殖、发生表型改变并通过直接和间接破坏功能成为炎症持续的中心环节,其作为间充质来源细胞,抑制可能不伴免疫抑制后果,是吸引人的细胞靶点。

研究设计与样本

  • 综述,旨在概述当前对FLS在RA中靶点潜力的认识。

主要发现

  • FLS存在于滑膜两层中,通过产生细胞外基质成分和润滑剂参与正常关节功能。
  • 在RA等炎症条件下,FLS可能开始增殖、发生表型改变,并通过直接和间接破坏功能成为炎症持续的中心元素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fibroblast-like synoviocytes or synovial fibroblasts (FLS) are important cellular components of the inner layer of the joint capsule, referred to as the synovial membrane. They can be found in both layers of this synovial membrane and contribute to normal joint function by producing extracellular matrix components and lubricants. However, under inflammatory conditions like in rheumatoid arthritis (RA), they may start to proliferate, undergo phenotypical changes and become central elements in the perpetuation of inflammation through their direct and indirect destructive functions. Their importance in autoimmune joint disorders makes them attractive cellular targets, and as mesenchymal-derived cells, their inhibition may be carried out without immunosuppressive consequences. Here, we aim to give an overview of our current understanding of the target potential of these cells in RA.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Németh T, Nagy G, Pap T, et al. Synovial fibroblasts as potential drug targets in rheumatoid arthritis, where do we stand and where shall we go? Ann Rheum Dis. 2022. PMID: 35715191. doi:10.1136/annrheumdis-2021-222021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。